The role of CXC chemokines in the transition of chronic inflammation to esophageal and gastric cancer.
about
Role of Chemokines in Non-Small Cell Lung Cancer: Angiogenesis and InflammationCXC chemokines and chemokine receptors in gastric cancer: from basic findings towards therapeutic targetingCarcinogenic Parasite Secretes Growth Factor That Accelerates Wound Healing and Potentially Promotes NeoplasiaLive imaging and gene expression analysis in zebrafish identifies a link between neutrophils and epithelial to mesenchymal transitionChemokines and chemokine receptors: update on utility and challenges for the clinician.Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasisA multi-targeted approach to suppress tumor-promoting inflammationHead-to-Head Comparison of Anti-Inflammatory Performance of Known Natural Products In VitroDiscovery and validation of an INflammatory PROtein-driven GAstric cancer Signature (INPROGAS) using antibody microarray-based oncoproteomicsScreening of surface markers on rat intestinal mucosa microfold cells by using laser capture microdissection combined with protein chip technology.Inhibition of CXCL12/CXCR4 axis as a potential targeted therapy of advanced gastric carcinomaResistin-induced stromal cell-derived factor-1 expression through Toll-like receptor 4 and activation of p38 MAPK/ NFκB signaling pathway in gastric cancer cells.Crucial involvement of tumor-associated neutrophils in the regulation of chronic colitis-associated carcinogenesis in miceChemokine (C-X-C) ligand 1 (CXCL1) protein expression is increased in aggressive bladder cancers.Curcumin inhibits gastric inflammation induced by Helicobacter pylori infection in a mouse model.Loss of gastric gland mucin-specific O-glycan is associated with progression of differentiated-type adenocarcinoma of the stomachThe prognostic value of CXC-chemokine receptor 2 (CXCR2) in gastric cancer patients.CTL- vs Treg lymphocyte-attracting chemokines, CCL4 and CCL20, are strong reciprocal predictive markers for survival of patients with oesophageal squamous cell carcinoma.Co-expressed differentially expressed genes and long non-coding RNAs involved in the celecoxib treatment of gastric cancer: An RNA sequencing analysis.Targeting chemokine pathways in esophageal adenocarcinoma.Isorhamnetin inhibits proliferation and invasion and induces apoptosis through the modulation of peroxisome proliferator-activated receptor γ activation pathway in gastric cancer.Local production of the chemokines CCL5 and CXCL10 attracts CD8+ T lymphocytes into esophageal squamous cell carcinoma.Impact of chemokine receptor CXCR3 on tumor-infiltrating lymphocyte recruitment associated with favorable prognosis in advanced gastric cancerRepertaxin, an inhibitor of the chemokine receptors CXCR1 and CXCR2, inhibits malignant behavior of human gastric cancer MKN45 cells in vitro and in vivo and enhances efficacy of 5-fluorouracilSentinel node and mechanism of lymphatic metastasis.Diversity in sequence-dependent control of GRO chemokine mRNA half-lifeChemokines, chemokine receptors and the gastrointestinal system.Emerging Targets in Pituitary Adenomas: Role of the CXCL12/CXCR4-R7 System.A novel signature for stratifying the molecular heterogeneity of the tissue-infiltrating T-cell receptor repertoire reflects gastric cancer prognosis.Disease monitoring of hepatocellular carcinoma through metabolomics.Cancer and inflammation.Macrophage Migration Inhibitory Factor (MIF) Supports Homing of Osteoclast Precursors to Peripheral Osteolytic Lesions.CXC and CC chemokines as angiogenic modulators in nonhaematological tumors.CAF-secreted CXCL1 conferred radioresistance by regulating DNA damage response in a ROS-dependent manner in esophageal squamous cell carcinoma.Inflammatory cytokines are associated with response and prognosis in patients with esophageal cancer.Circulating Inflammation Markers, Risk of Lung Cancer, and Utility for Risk Stratification.Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness.C-C motif chemokine receptors in gastric cancer.Expression profile of cytokines in gastric cancer patients using proteomic antibody microarray.A common molecular signature of intestinal-type gastric carcinoma indicates processes related to gastric carcinogenesis.
P2860
Q26796395-476334C9-3B1E-4B5C-89DC-5E28137F48A9Q26849606-4773F8AD-3D6D-4F5F-9313-F86DD30BFC2AQ27317022-E05EAA1B-A6ED-4A84-AE89-2C6FD520F052Q27330504-BDFE874C-6EE5-4367-A43F-D72508AE4E11Q27687402-8292EF34-731D-4FA1-B691-FD3523A1F3D9Q28069422-AEB2E370-506A-4DB0-A1AA-4D07898FE0CCQ28393278-F2A708DA-79FD-40C8-A403-D8190E887EDDQ28551910-72E037DF-FD1C-42AA-9AED-629B6FBB8749Q33688456-276EF83C-FE8D-4E40-97CA-80DEF4ABBC88Q33756249-344782EF-44EB-462D-9084-E5A0CEFAB34EQ33775283-F468B6E3-73F9-441C-947C-F9656E7B1781Q33872957-EC5FBA6A-1377-48A1-B0E2-6CBDC6546DF5Q34525747-DC405221-57E4-4A8B-8CBA-34BB6ED528E2Q34788410-F79F11B6-B235-4165-83C7-4FCDAEAA4DCEQ35003794-943A7EA9-3261-47A4-92A0-18BFE688EB3FQ35051690-0899D65A-34C0-4798-A3E0-4AA2F7FEBB08Q35819575-4809111B-E218-4786-8061-84D511708048Q36027105-5E84FD44-13A7-4A44-B560-33F847F16B3DQ36152244-7BEE994C-4F98-40A2-80E7-C01E083E25F0Q36187424-015B8F28-9899-4F3C-BE8F-ACF37E789AEEQ36368271-EE3C703E-5A86-4760-A25B-C821A439D139Q36413088-9AC7DF46-99EB-4D55-8418-95AFCA05FFB2Q36464594-954EBAD5-AF11-44CB-8320-16D4809B0054Q36649559-C40F5CFA-13B7-4F85-A759-4D84F0A7BE5CQ36679422-DE528D76-8CC9-420B-8814-BC6C4F78FE76Q36850466-3C1D3A34-D77F-45AE-8FAC-0282D960B938Q38109160-D928B9A9-C59C-4945-934E-6C736DDCC8D5Q38284921-2FAC0A00-854C-4340-B7D1-DCBEB69FAF22Q38629690-7D40F669-FB41-4771-B2F2-F8DE71263191Q38768256-4EB26F48-6D38-43C8-BD1C-B82C83ADFF8FQ39036378-794191C0-5380-4A71-8589-B3385E3001E3Q39848278-3C173652-852D-410D-A746-BF8DD5E2A25FQ40724369-B357FB20-1151-493C-A32F-E700D784E92DQ41082538-5D2447BF-049D-453A-99A0-168168F49692Q41471150-79A85EDA-8A8D-4DBF-97C0-0DB1F448B86EQ41536252-19B5E191-4337-444C-B422-488862558F90Q42371988-73395A64-2896-4210-A9A3-F741AD0F27AAQ47163024-E21D4F45-DA19-44AE-84ED-04E0C8542CD7Q49986690-48AFF6AD-BC69-43EB-9A0A-C44DFC3DFD02Q52684153-FB0213FB-70B6-48B6-8796-29F95FCDD888
P2860
The role of CXC chemokines in the transition of chronic inflammation to esophageal and gastric cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
The role of CXC chemokines in ...... esophageal and gastric cancer.
@en
The role of CXC chemokines in ...... esophageal and gastric cancer.
@nl
type
label
The role of CXC chemokines in ...... esophageal and gastric cancer.
@en
The role of CXC chemokines in ...... esophageal and gastric cancer.
@nl
prefLabel
The role of CXC chemokines in ...... esophageal and gastric cancer.
@en
The role of CXC chemokines in ...... esophageal and gastric cancer.
@nl
P1476
The role of CXC chemokines in ...... esophageal and gastric cancer
@en
P2093
Hannelien Verbeke
Karel Geboes
P304
P356
10.1016/J.BBCAN.2011.10.008
P407
P577
2011-11-04T00:00:00Z